Michaela Pereckas

Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

15 publications 2002 – 2025 ORCID

What does Michaela Pereckas research?

Michaela Pereckas studies the role of nitric oxide in the function of pancreatic cells that produce insulin. Insulin is essential for regulating blood sugar levels, and her work specifically looks at how nitric oxide can interrupt the process these cells use to take in glucose. By examining the energy dynamics within these insulin-producing cells, she aims to uncover why they sometimes fail, contributing to conditions like diabetes. Her findings may inform future diabetes treatments that better target these vulnerable pancreatic cells.

Key findings

  • Nitric oxide inhibits glucose uptake in pancreatic insulin cells by blocking their energy supply, causing ATP levels to drop significantly.
  • The research shows that this inhibition leads to a dormant state in insulin-producing cells, impairing their ability to manage blood sugar levels.
  • Understanding this unique vulnerability of insulin cells could pave the way for innovative treatments for diabetes.

Frequently asked questions

Does Dr. Pereckas study diabetes?
Yes, Dr. Pereckas' research is directly related to diabetes as it investigates how insulin-producing cells function and react to nitric oxide.
What treatments has Dr. Pereckas researched?
While Dr. Pereckas is primarily focused on understanding cellular mechanisms, her findings could lead to new treatment strategies for improving insulin function in diabetic patients.
Is Dr. Pereckas' work relevant to patients with blood sugar control issues?
Yes, her research addresses the challenges faced by insulin-producing cells in managing blood sugar, which is highly relevant to patients with conditions like diabetes.

Publications in plain English

Correction: Maranto et al. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.2020,, 3412.

2025

Cancers

Maranto C, Udhane V, Jia J, Verma R, Müller-Newen G +9 more

PubMed

Studying the O-GlcNAcome of human placentas using banked tissue samples.

2024

Glycobiology

Luna S, Malard F, Pereckas M, Aoki M, Aoki K +1 more

Plain English
This study focused on analyzing specific proteins in human placentas that are modified by a process called O-GlcNAcylation, which plays a key role in signaling within cells. Researchers used tissue samples from two pregnancies and successfully identified over 2,000 unique protein modifications, as well as 82 proteins that are highly expressed in the placenta. This research is important because it lays the groundwork for developing new diagnostic tools and treatments for various human diseases by better understanding these protein modifications. Who this helps: This helps patients and doctors looking for better ways to diagnose and treat diseases.

PubMed

Proteomic Profiles of Human Arterioles Isolated From Fresh Adipose Tissue or Following Overnight Storage.

2024

Laboratory investigation; a journal of technical methods and pathology

Pandey R, Roberts ML, Wang J, Pereckas M, Jensen D +3 more

Plain English
This study looked at tiny blood vessels called arterioles taken from human fat tissue to understand their protein makeup. Researchers discovered a way to analyze more than 3,000 proteins in these vessels, even after storing them overnight, which makes the process easier for future research. About 12.5% of proteins related to blood pressure were found in the arterioles, indicating these proteins are important for understanding how blood pressure works. Who this helps: This helps researchers studying blood pressure and vascular health.

PubMed

HLA-DR-Expressing Fibroblast-Like Synoviocytes Are Inducible Antigen Presenting Cells That Present Autoantigens in Lyme Arthritis.

2024

ACR open rheumatology

Rouse JR, Danner R, Wahhab A, Pereckas M, Nguyen C +5 more

Plain English
This study focused on specific cells called fibroblast-like synoviocytes (FLS) that are found in the joints of people with Lyme arthritis. Researchers discovered that these cells can present important pieces of proteins (called antigens) to the immune system, which can stimulate an immune response; for example, they found that FLS presented a piece of a Lyme-related protein in a way that activated CD4+ T cells. This matters because it suggests that FLS may play a role in worsening joint inflammation by triggering the immune system to attack the body's own tissues in Lyme arthritis. Who this helps: This benefits patients with Lyme arthritis by improving our understanding of disease mechanisms.

PubMed

Identification of Major Histocompatibility Complex Class II Epitopes From Lyme Autoantigen Apolipoprotein B-100 and Borrelia burgdorferi Mcp4 in Murine Lyme Arthritis.

2024

The Journal of infectious diseases

Danner R, Prochniak LM, Pereckas M, Rouse JR, Wahhab A +2 more

Plain English
This study looked at how the immune system reacts in mice infected with the Lyme bacteria, Borrelia burgdorferi, especially in relation to Lyme arthritis. Researchers found that a specific protein from the host, called apolipoprotein B-100, showed a significant increase in immune response as the infection progressed, particularly in mice that had severe, long-lasting arthritis. Only one peptide from the Lyme bacteria triggered an immune response, suggesting that the immune system isn't reacting strongly enough to fight the infection. Who this helps: This research benefits patients with Lyme disease and doctors treating them.

PubMed

Lysosomal enzyme binding to the cation-independent mannose 6-phosphate receptor is regulated allosterically by insulin-like growth factor 2.

2024

Scientific reports

Bohnsack RN, Misra SK, Liu J, Ishihara-Aoki M, Pereckas M +4 more

Plain English
This study looked at how a protein called the cation-independent mannose 6-phosphate receptor (CI-MPR) interacts with lysosomal enzymes and the hormone insulin-like growth factor 2 (IGF2). The researchers found that IGF2 changes the shape of CI-MPR, which prevents it from binding to lysosomal enzymes effectively. This is important because understanding these interactions can help in treating lysosomal storage diseases, where enzyme delivery is crucial for patient health. Who this helps: This benefits patients with lysosomal storage diseases who need effective treatments.

PubMed

-GlcNAcylation regulates OTX2's proteostasis.

2023

iScience

Wulff-Fuentes E, Boakye J, Kroenke K, Berendt RR, Martinez-Morant C +3 more

Plain English
This study explored how a specific modification called -GlcNAcylation affects the stability of a brain protein named OTX2, which is linked to disorders like hormone deficiencies and eye diseases. Researchers found that under normal conditions, a cellular process breaks down OTX2 effectively, but when OTX2 levels are too high, it can clump together and become problematic. The findings showed that -GlcNAcylation helps keep OTX2 soluble, reducing these harmful clumps, and that there’s a cooperative relationship with another protein that may help protect against aggregation. Who this helps: This benefits patients with brain disorders related to OTX2, as well as doctors who treat these conditions.

PubMed

Human leukocyte antigen HLA-DR-expressing fibroblast-like synoviocytes are inducible antigen presenting cells that present autoantigens in Lyme arthritis.

2023

bioRxiv : the preprint server for biology

Rouse JR, Danner R, Wahhab A, Pereckas M, McClune ME +4 more

Plain English
This study looked at specific cells in the joints of people with Lyme arthritis and how they might trigger immune responses. Researchers found that certain cells, called fibroblast-like synoviocytes, can present proteins from Lyme bacteria and the body’s own tissues to immune cells, which can lead to increased inflammation. This is important because it helps explain why patients with Lyme arthritis continue to have symptoms even after the infection is gone. Who this helps: Patients suffering from Lyme arthritis.

PubMed

β-cell-selective inhibition of DNA damage response signaling by nitric oxide is associated with an attenuation in glucose uptake.

2023

The Journal of biological chemistry

Yeo CT, Kropp EM, Hansen PA, Pereckas M, Oleson BJ +5 more

Plain English
Researchers studied how nitric oxide (a molecule produced in the body) affects insulin-producing cells in the pancreas, and found that it shuts down the cells' ability to take in and process glucose (sugar) by depleting their energy supply. The nitric oxide specifically blocks the cells' energy-making machinery in their mitochondria, causing ATP (the cell's fuel) to drop so low that the cells can no longer absorb glucose, putting them into a dormant state. This matters because it reveals a unique vulnerability of pancreatic insulin cells compared to other cell types, which could help explain problems with blood sugar control and potentially lead to new treatments for diabetes.

PubMed

O-GlcNAcylation Is Essential for Rapid Pomc Expression and Cell Proliferation in Corticotropic Tumor Cells.

2021

Endocrinology

Massman LJ, Pereckas M, Zwagerman NT, Olivier-Van Stichelen S

Plain English
This study looked at a specific chemical modification, called O-GlcNAcylation, and how it affects tumor cells in the pituitary gland, particularly those that cause a condition known as Cushing disease. Researchers found that in aggressive tumors, increased levels of O-GlcNAcylation were linked to faster cell growth and higher production of a hormone (ACTH) that leads to serious health issues. This is important because understanding the role of O-GlcNAcylation could help develop treatments for patients suffering from these types of tumors and related hormonal disorders. Who this helps: Patients with pituitary tumors and Cushing disease.

PubMed

Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.

2020

Cancers

Maranto C, Udhane V, Jia J, Verma R, Müller-Newen G +9 more

Plain English
The study looked at a new drug called IST5-002, which targets a protein involved in prostate cancer. Researchers found that this drug effectively blocks the activity of the protein responsible for cancer cell growth without causing significant toxic effects in mice. The results showed that IST5-002 could be a safe and effective treatment option for patients with prostate cancer and certain blood disorders. Who this helps: Patients with prostate cancer and related blood disorders.

PubMed

SP2: Rapid and Automatable Contaminant Removal from Peptide Samples for Proteomic Analyses.

2019

Journal of proteome research

Waas M, Pereckas M, Jones Lipinski RA, Ashwood C, Gundry RL

Plain English
This study looked at a new method called SP2, which uses special tiny beads to clean peptides (small protein fragments) by removing unwanted substances that can interfere with analysis. Researchers found that SP2 effectively cleans these samples while also making them easier to analyze using standard laboratory techniques. Specifically, the method is helpful for cleaning more complex samples like phosphopeptides and glycopeptides and can be automated for high-throughput processing. Who this helps: This benefits researchers and laboratories that analyze proteins, particularly those facing challenges with sample contamination.

PubMed

Isomer-specific effect of microRNA miR-29b on nuclear morphology.

2018

The Journal of biological chemistry

Kriegel AJ, Terhune SS, Greene AS, Noon KR, Pereckas MS +1 more

Plain English
This study looked at how a specific form of a molecule called microRNA, named miR-29b, influences the shape of the nucleus during cell division. Researchers found that when they blocked miR-29b, the cells showed significant irregularities in their nuclear shape, which did not happen when they blocked a similar molecule, miR-29a. They discovered that miR-29b interacts with certain proteins in the cell that help maintain nuclear shape during division, highlighting its unique and important role. Who this helps: Patients with cell division-related diseases, like cancer, might benefit from these insights for future treatments.

PubMed

Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.

2007

Cellular microbiology

Maresso AW, Deng Q, Pereckas MS, Wakim BT, Barbieri JT

Plain English
Researchers studied how the toxin ExoS produced by the bacteria Pseudomonas aeruginosa affects certain proteins in human cells, particularly those involved in cell structure and signaling. They found that ExoS prevents important proteins (Ezrin/Radixin/Moesin) from being properly modified, which is crucial for their function; specifically, it decreased their phosphorylation, making them less responsive to signals that help maintain cell shape. The understanding of how this bacterial toxin disrupts cell function is important because it sheds light on the mechanisms of severe infections, particularly in vulnerable patients. Who this helps: This research benefits doctors treating patients with severe infections, especially those with weakened immune systems or cystic fibrosis.

PubMed

Sequencing hydroxyethylamine-containing peptides via Edman degradation.

2002

Organic letters

Brewer M, Oost T, Sukonpan C, Pereckas M, Rich DH

Plain English
This study focused on a method called Edman degradation to identify the sequences of specific peptides that contain hydroxyethylamine. The researchers found that this technique successfully gives detailed information about the peptide structure, which is important for understanding how these modified peptides behave in biological systems. This matters because knowing the exact sequence can help in developing new therapies that target these peptides more effectively. Who this helps: This helps researchers and developers in the field of biomedicine.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.